Which has preferable valuation & earnings, SRZNW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Surrozen $11.51M N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is SRZNW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Surrozen N/A N/A N/A Alvotech N/A N/A N/A

Which has preferable valuation and earnings, SRZNW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Surrozen $11.51M N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is SRZNW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets Surrozen N/A N/A N/A Apollomics N/A N/A N/A

Which has better valuation and earnings, SRZNW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Surrozen $11.51M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is SRZNW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Surrozen N/A N/A N/A Aravive N/A N/A N/A

Which has preferable earnings & valuation, BIAFW or SRZNW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio bioAffinity Technologies $5.85M N/A N/A N/A N/A Surrozen $11.51M N/A N/A N/A N/A

Is BIAFW or SRZNW more profitable?

Company Net Margins Return on Equity Return on Assets bioAffinity Technologies N/A N/A N/A Surrozen N/A N/A N/A

Which has higher valuation and earnings, SRZNW or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Surrozen $11.51M N/A N/A N/A N/A BioVie N/A N/A N/A N/A N/A

Is SRZNW or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets Surrozen N/A N/A N/A BioVie N/A N/A N/A

Surrozen (SRZNW) Competitors

$0.0015 0.00 (0.00%)

As of 08/7/2026

Compare

SRZNW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Surrozen stock or one of its competitors? Surrozen's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Surrozen compare to Alvotech?

Surrozen (NASDAQ:SRZNW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

In the previous week, Alvotech had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for Surrozen. Alvotech's average media sentiment score of 0.92 beat Surrozen's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Surrozen	Neutral
Alvotech	Positive

Company	Net Margins	Return on Equity	Return on Assets
Surrozen	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surrozen	$11.51M	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Summary

Alvotech beats Surrozen on 3 of the 3 factors compared between the two stocks.

How does Surrozen compare to Apollomics?

Surrozen (NASDAQ:SRZNW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surrozen	$11.51M	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

In the previous week, Surrozen's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company	Overall Sentiment
Surrozen	Neutral
Apollomics	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Surrozen	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

Summary

Surrozen beats Apollomics on 1 of the 1 factors compared between the two stocks.

How does Surrozen compare to Aravive?

Surrozen (NASDAQ:SRZNW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

In the previous week, Surrozen's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
Surrozen	Neutral
Aravive	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surrozen	$11.51M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

Company	Net Margins	Return on Equity	Return on Assets
Surrozen	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Aravive beats Surrozen on 2 of the 3 factors compared between the two stocks.

How does Surrozen compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Surrozen (NASDAQ:SRZNW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

In the previous week, bioAffinity Technologies had 2 more articles in the media than Surrozen. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for Surrozen. Surrozen's average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.66 indicating that Surrozen is being referred to more favorably in the news media.

Company	Overall Sentiment
bioAffinity Technologies	Negative
Surrozen	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A
Surrozen	$11.51M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	N/A	N/A	N/A
Surrozen	N/A	N/A	N/A

Summary

Surrozen beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does Surrozen compare to BioVie?

Surrozen (NASDAQ:SRZNW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surrozen	$11.51M	N/A	N/A	N/A	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

In the previous week, BioVie had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for BioVie and 0 mentions for Surrozen. Surrozen's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company	Overall Sentiment
Surrozen	Neutral
BioVie	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Surrozen	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

Summary

Surrozen and BioVie tied by winning 1 of the 2 factors compared between the two stocks.

Get Surrozen News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRZNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRZNW vs. The Competition

Export

Metric	Surrozen	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$4.02B	$7.25B	$12.89B
Dividend Yield	N/A	3.61%	2.53%	8.56%
P/E Ratio	N/A	12.72	273.59	25.44
Price / Sales	N/A	1,361.39	675.80	123.63
Price / Cash	N/A	105.29	76.98	52.08
Price / Book	N/A	16.29	12.89	6.14
Net Income	N/A	-$22.72M	$3.47B	$349.01M
7 Day Performance	N/A	-1.37%	-0.32%	-1.47%
1 Month Performance	N/A	11.08%	6.52%	2.47%
1 Year Performance	N/A	53.72%	25.19%	15.84%

Surrozen Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRZNW Surrozen	N/A	$0.00 flat	N/A	-93.1%	$0.00	$11.51M	N/A	80	High Trading Volume
ALVOW Alvotech	N/A	$0.38 flat	N/A	N/A	$0.00	$491.95M	N/A	4	Gap Up
APLMW Apollomics	N/A	$0.01 -2.1%	N/A	+74.7%	$0.00	$8.50M	N/A	59	Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.08 flat	N/A	+519.7%	$0.00	$5.85M	N/A	10	News Coverage Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRZNW) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Surrozen (SRZNW) Competitors